Skip to main content
Premium Trial:

Request an Annual Quote

Erasmus Medical Center Uses SGI System for Data Visualization

NEW YORK, April 10 (GenomeWeb News) - ErasmusMedicalCenter said today that it has added server and visualization systems from Silicon Graphics to its hospital and research facility in Rotterdam, The Netherlands.

 

The new SGI systems will be used to support I-space, an immersive, interactive environment developed at Erasmus Medical Center that runs software designed to convert 2D medical images into 3D. The center is using the system for genomic and proteomic data mining, as well as for visualizing MRI scans, CT scans, and ultrasound images.

 

"There are eight graphics pipes in the [I-space] system -- you are actually standing inside the data -- so we required a visualization computer that is powerful enough to really do the rendering of the 3D software in a very efficient way, and only SGI had the appropriate solution," said Ronald Nanninga, founder and managing director of Crosslinks, a spin off of Erasmus Medical Center that is marketing the I-space technology, in a statement.

 

The prototype I-space system runs on a Silicon Graphics Prism visualization system with 8 Intel Itanium 2 processors, 8 ATI FireGL graphics processors, and 12 GB of memory. The medical center also runs a 32-processor SGI Origin(R) 3800 server.

 

Financial terms of the deal with SGI were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.